The Power of Cardiovascular Genetic Testing: From Implementation to Targeted Therapies with Sharlene M. Day, MD

This webinar will discuss strategies to increase familiarity and knowledge about the appropriate use of genetic testing in the community. This is challenging because of the lean numbers of genetic counselors available and the rapid evolution of genetic testing options and variant interpretation algorithms. Development of novel therapeutics for HCM, DCM, and ACM and how these are increasingly targeted to specific genotypes will also be discussed.

Level of Instruction: Advanced

Only the live session qualifies for CEUs but when possible, we host the recordings on our website and NSGC recommends participants to use their personal email instead of work email addresses to ensure they receive their CEU certificates.

Ambry Genetics is approved as a provider for continuing education program by NSGC and ASCLS P.A.C.E ® Program.

Sharlene Day, MD | Presenter

Associate Professor of Medicine and Genetics at Penn State

Sharlene M. Day, MD earned her B.S from the Massachusetts Institute of Technology in 1991 and her MD from New York University School of Medicine in 1995. She completed her internal medicine residency and cardiovascular medicine fellowship at the University of Michigan, followed by a postdoctoral research fellowship in cardiovascular biology and physiology. Shortly after joining the faculty at the University of Michigan, she established the Program for Inherited Cardiomyopathies and Arrhythmias, where she served as the Director for 12 years. Dr. Day joined the Penn faculty in July 2019 as Associate Professor of Medicine and Genetics and Director of Translational Research for the Division of Cardiovascular Medicine and the Cardiovascular Institute. She sees patients with genetic heart conditions in the Penn Center for Inherited Cardiac Disease. Her research program primarily focuses on hypertrophic cardiomyopathy (HCM), and integrates basic, translational and clinical science. She has published over 130 manuscripts and lectures nationally and internationally. Dr. Day is past chair of the NIH Translational Development and Clinical Studies Study Section, a member of the American Heart Association and American College of Cardiology National Committee for Establishing Treatment Guidelines for Patients with Hypertrophic Cardiomyopathy, past-Chair and current Board of Director member of the Sarnoff Foundation Scientific Committee, an elected member of the American Society of Clinical Investigation, and Associate Editor for The European Heart Journal and JAMA Cardiology.

Victoria Suslovitch, MS, CGC | Moderator

Genomic Science Liaison

Victoria is a licensed and certified genetic counselor, and a Genomic Science Liaison for the Rare Disease, Neurology, and Cardiology group with Ambry Genetics. Prior to joining Ambry, Victoria was a research genetic counselor at Boston Children’s Hospital, for a study that aims to develop genomically targeted therapies for children with rare neurological diseases. She received her Bachelor of Arts in Biology from the University of Tampa, and Master of Science in Genetic Counseling from Boston University.